Spire Health says its patient monitoring tech reduces admissions
By HME News Staff
Updated 9:16 AM CDT, Tue March 14, 2023
SAN FRANCISCO – Spire Health has published the results of a survey in the International Journal of COPD that shows use of its virtual care system is associated with a reduction in emergency visits and hospital admissions for COPD patients. Use of Spire’s sensing technology for long-term patient monitoring was associated with a significant decrease in all-cause hospitalizations per patient per year (1.09 ± 0.07 to 0.38 ± 0.06, P<0.001) and cardiopulmonary-specific admissions (0.70 ± 0.08 to 0.25 ± 0.05, P<0.001). The number of outpatient pulmonary visits, however, increased (4.22 ± 0.24 to 4.78 ± 0.28, P<0.05), suggesting Spire was redirecting care from acute to less expensive settings. "Results such as these are the reason I recently joined Spire as its new CEO," said Michael J. Doyle, CEO of Spire Health. "Our clients want to live in the comfort of their homes and avoid frequent trips to the emergency room or hospital. For COPD patients, Spire can help make this possible. Because at Spire, every breath counts." The study, which was approved by the Western Institutional Review Board and conducted at a multi-provider pulmonary practice, included 126 COPD patients who had at least one unplanned hospitalization or emergency room visit in the year prior to enrollment. The study had a mean device adherence in the cohort of 88.6% ± 1.1% of days with at least 8 hours of wear time due to, the company says, the ease of use of its Spire Health tag, which easily adheres to clothing and lasts up to 12 months without charging.
Comments